Nexavar®, Sorafenib is anti cancer drug multikinase inhibitor, film coated tablets, indicated for the treatment of:
- Renal cell carcinoma
Nexavar is indicated for the treatment of patients with advanced renal cell carcinoma. - Hepatocellular Carcinoma
Nexavar is indicated for the treatment of patients with hepatocellular carcinoma see section - Differentiated thyroid carcinoma
Nexavar is indicated for the treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma, refractory to radioactive iodine.
